|
|
|
|
|
| |
Clinical Trial Results - Tricor |
|
|
|
|
|
|
|
|
|
| CFEN0203 |
A randomized, double-blind trial comparing the efficacy and safety of fenofibrate, metformin, their combination and placebo in patients with metabolic syndrome |
Results summary
|
M. Nieuwdorp, E.S.G. Stroes and J.J.P Kastelein Normalisation of metabolic syndrome using fenofibrate metformin or their combination. Diabetes. Obesity and Metabolism. 9, 2007, 869-878
|
| CFEN0205 |
A randomised, double-blind, placebo-controlled study assessing the effect of fenofibrate, coenzyme Q10 and their co-administration on ventricular diastolic function in patients with type 2 diabetes |
Results summary
|
Gerard T Chew and al, Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction. Diabetes Care 2008
|
| CLF230121-0301 |
A randomized, double-blind trial assessing the efficacy and safety of low and standard doses of fenofibrate in combination with metformin on the lipid profile in patients with type 2 diabetes and dyslipidemia. |
Results summary
|
none available
|
|
CLF178P-0401
|
A randomised, double-blind study comparing the efficacy and safety of 145 mg NanoCrystal® fenofibrate, 10 mg ezetimibe and their combination in patients with type IIb dyslipidemia and features of the metabolic syndrome. |
Results summary
|
none available
|
| CLF230121-0503 |
Assessment of insulin sensitivity in type 2 diabetics treated with metformin, fenofibrate and their combination |
Results summary
|
none available
|
| |
|
|
|
|
|
|
|
|
|
|
|
